Ezetimibe impairs uptake of dietary cholesterol oxidation products and reduces alterations in hepatic cholesterol metabolism and antioxidant function in rats

Lipids

Volumn 48, Issue 6, 2013, Pages 587-595

  Terunuma, Shoichiro ^a   Kumata, Noriko ^a   Osada, Kyoichi ^a  

^a MEIJI UNIVERSITY   (Japan)

Author keywords

Cholesterol; Cholesterol oxidation products; Ezetimibe; Fatty acids; Neutral steroid; Rat; SREBP

Indexed keywords

CHOLESTEROL; CHOLESTEROL OXIDATION PRODUCT; EZETIMIBE; FERRIC ION; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTERIOSCLEROSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL EXCRETION; CHOLESTEROL INTAKE; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; EXCRETION; FATTY ACID SYNTHESIS; FECES; GENE EXPRESSION; GENETIC TRANSCRIPTION; LIVER LEVEL; LIVER METABOLISM; MALE; NONHUMAN; RAT;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; AZETIDINES; BODY WEIGHT; CHOLESTEROL, DIETARY; FECES; LIPID METABOLISM; LIPIDS; LIVER; MALE; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84878590689     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-013-3790-6     Document Type: Article

References (47)

1. Sottero B, Gamba P, Gargiulo S, Leonarduzzi G, Poli G (2009) Cholesterol oxidation products and disease: an emerging topic of interest in medicinal chemistry. Curr Med Chem 16:685-705
2. Yuan XM, Li W, Btunk UT, Dalen H, Chang YH, Sevanian A (2000) Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products. Free Radic Biol Med 28:208-218
3. Larsson DA, Baird S, Nyhalah D, Yuan X-M, Li W (2006) Oxysterol mixtures, in atheroma-relevant proportions, display synergistic and proapoptotic effects. Free Radic Biol Med 41:902-910
4. Paniangvait P, King AJ, Jones AD, German B (1995) Cholesterol oxides in foods of animal origin. J Food Sci 60:1159-1174
5. Lake RJ, Scholes P (1997) Quality and consumption of oxidized lipids from deep-frying fats and oils in New Zealand. J Am Oil Chem Soc 74:1065-1068
6. Lake RJ, Scholes P (1997) Consumption of cholesterol oxides from fast foods fried in beef fat in New Zealand. J Am Oil Chem Soc 74:1069-1075
7. Ryan E, Chopra J, McCarthy F, Maguire AR, O'Brien NM (2005) Qualitative and quantitative comparison of the cytotoxic and apoptotic potential of phytosterol oxidation products with their corresponding cholesterol oxidation products. Br J Nutr 94:443-451
8. Osada K, Minehira K, Inoue S, Nakamura S, Yamada K, Sugano M (2000) Effect of oxidized cholesterol on age-associated changes to immune parameters in spleen lymphocytes and peritoneal exudate cells derived from rats. Biosci Biotech Biochem 64:1047-1051
9. Lemaire-Ewing S, Prunet C, Montange T, Vejux A, Berthier A, Bessède G, Corcos L, Gambert P, Néel D, Lizard G (2005) Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol Toxicol 21:97-114
10. Davis HR, Veltri EP (2007) Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia. J Atheroscler Thromb 14:99-108
11. Altmann SW, Davis HR, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SPN, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, Graziano MP (2004) Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303:1201-1204
12. Davis HR, Zhu LJ, Hoos LM, Tetzloff G, Maguire M, Liu J, Yao X, Iyer SPN, Lam MH, Lund EG, Detmers PA, Graziano MP, Altmann SW (2004) Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. Biol Chem 279:33586-33592
13. Sané AT, Sinnett D, Delvin E, Bendayan M, Marcil V, Ménard D, Beaulieu JF, Levy E (2006) Localization and role of NPC1L1 in cholesterol absorption in human intestine. J Lipid Res 47:2112-2120
14. Ge L, Wang J, Qi W, Miao HH, Cao J, Qu YX, Li BL, Song BL (2008) The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1. Cell Metab 7:508-519
15. Deushi M, Nomura M, Kawakami A, Haraguchi M, Ito M, Okazaki M, Ishii H, Yoshida M (2007) Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. FEBS Lett 581:5664-5670
16. -/- mice. Am J Physiol Gastrointest Liver Physiol 295:G776-G783
17. Assy N, Grozovski M, Bersudsky I, Szvalb S, Hussein O (2006) Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease. World J Gastroenterol 12:4369-4376
18. Zheng S, Hoos L, Cook J, Tetzloff G, Davis H, Van Heek M, Hwa JJ (2008) Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice. Eur J Pharmacol 584:118-124
19. Minehira K, Inoue S, Nonaka M, Osada K, Yamada K, Sugano M (2000) Effects of dietary protein type on oxidized cholesterol-induced alteration in age-related modulation of lipid metabolism and indices of immune function in rats. Biochim Biophys Acta 1483:141-153
20. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipid from animal tissues. J Biol Chem 226:497-509
21. Ide T, Okamatsu H, Sugano M (1978) Regulation by dietary fats of 3-hydroxy-3-methylglutaryl-Coenzyme A reductase in rat liver. J Nutr 108:601-612
22. Burchard H (1890). Beiträge zur Kenntnis des Cholesterins. Chem Zentralb l61:25-27
23. Osada K, Kodama T, Yamada K, Sugano M (1993) Oxidation of cholesterol by heating. J Agric Food Chem 41:1198-1202
24. Ueda T, Igarashi O (1987) New solvent system for extraction of tocopherols from biological specimens for HPLC determination and the evaluation of 2,2,5,7,8-pentamethyl-6-chromanol as an internal standard. J Micronutr Anal 3:185-198
25. Ma S-W, Tomlinson B, Benzie IF (2005) A study of the effect of oral glucose loading on plasma oxidant: antioxidant balance in normal subjects. Eur J Nutr 44:250-254
26. Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 239:70-76
27. Nakatsugawa K, Kaneda T (1981) Absorption of methyl linoleate hydroperoxides in rabbit. J Jpn Oil Chem Soc 30:74-77
28. Nakatsugawa K, Kaneda T (1983) Absorption and metabolism of methyl linoleate hydroperoxides in rats. J Jpn Oil Chem Soc 32:361-366
29. Osada K, Kodama T, Yamada K, Nakamura S, Sugano M (1998) Dietary oxidized cholesterol modulates cholesterol metabolism and linoleic acid desaturation in rats fed high-cholesterol diets. Lipids 33:757-764
30. Smith LL, Johnson BH (1989) Biological activities of oxysterols. Free Radic Biol Med 7:285-332
31. Osada K, Inoue T, Nakamura S, Sugano M (1999) Dietary soybean protein moderates the deleterious disturbance of lipid metabolism caused by exogenous oxidized cholesterol in rats. Biochim Biophys Acta 1427:337-350
32. Ogino Y, Osada K, Nakamura S, Ohta Y, Kanda T, Sugano M, Ogino Y (2007) Absorption of dietary cholesterol oxidation products and their downstream metabolic effects are reduced by dietary apple polyphenols. Lipids 42:151-161
33. Osada K, Sasaki E, Sugano M (1994) Inhibition of cholesterol absorption by oxidized cholesterol in rats. Biosci Biotech Biochem 58:782-783
34. Schroepfer GJ Jr (2000) Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 80:361-554
35. Van Heek M, Farley C, Compton DS, Hoos L, Alton KB, Sybertz EJ, Davis HR (2000) Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. Br J Pharmacol 129:1748-1754
36. Bays HE, Moore PB, Drehobl MA, Rosenblatt S, Toth PD, Dujovne CA, Knopp RH, Lipka LJ, Lebeaut AP, Yang B, Mellars LE, Cuffie-Jackson C, Veltri EP (2001) Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies. Clin Ther 23:1209-1230
37. Dujovne CA, Ettinger MP, McNeer JF, Lipka LJ, LeBeaut AP, Suresh R, Yang B, Veltri EP (2002) Efficacy and safety of a potent new inhibitor, ezetimibe, in patients with primary hypercholesterolemia. Am J Cardiol 90:1092-1097
38. Knopp R (2003) Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. Eur Heart J 24:729-741
39. Sudhop T (2002) Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 106:1943-1948
40. Repa JJ, Turley SD, Quan G, Dietschy JM (2005) Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption. J Lipid Res 46:779-789
41. Staprans I, Pan XM, Rapp JH, Moser AH, Feingold KR (2006) Ezetimibe inhibits the incorporation of dietary oxidized cholesterol into lipoproteins. J Lipid Res 47:2575-2580
42. Narushima K, Takada T, Yamanashi Y, Suzuki H (2008) Niemann-Pick C1-like 1 mediates alpha-tocopherol transport. Mol Pharmacol 74:42-49
43. Fernandez-Hernando C, Moore KJ (2011) MicroRNA modulation of cholesterol homeostasis. Arterioscler Thromb Vasc Biol 31:2378-2382
44. Adams CM, Reitz J, De Brabander JK, Feramisco JD, Li L, Brown MS, Goldstein JL (2004) Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J Biol Chem 279:52772-52780
45. Radhakrishnan A, Ikeda Y, Kwon HJ, Brown MS, Goldstein JL (2007) Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc Natl Acad Sci USA 104:6511-6518
46. Osada K, Kodama T, Noda S, Yamada K, Sugano M (1995) Oxidized cholesterol modulates age-related change in lipid metabolism in rats. Lipids 30:405-413
47. Jump DB, Botolin D, Wang Y, Xu J, Christian B, Demeure O (2005) Fatty acid regulation of hepatic gene transcription. J Nutr 135:2503-2506